Changes in socioeconomic, environmental, and ecological factors in recent decades are probably responsible for the significant increase of emerging infectious diseases, the majority of which are zoonotic \[[@CIT0001]\]. Of particular concern are emerging respiratory viruses of the families Orthomyxoviridae \[[@CIT0002], [@CIT0003]\], Coronaviridae \[[@CIT0004], [@CIT0005]\], and Paramyxoviridae \[[@CIT0006], [@CIT0007]\]. The use of novel molecular techniques has made it possible to identify previously unsuspected or unknown viruses \[[@CIT0008]\]. However, it is important to assess the clinical and public health relevance of these viruses by determining their origin and establishing their impact in the human population.

The impetus for the current study was the identification of a virus related to avian paramyxovirus type 1 (APMV-1) from a fatal human case of unknown cause in the Netherlands by viral metagenomics analysis \[[@CIT0008]\]. APMV-1 is classified in the genus *Avulavirus*, family Paramyxoviridae \[[@CIT0009]\]. Infection with APMV-1 is mainly restricted to birds, but occasionally causes mild disease---usually transient conjunctivitis---in humans \[[@CIT0010]\]. So far, there is only one case report, from New York State, of a person who died with APMV-1 infection \[[@CIT0011]\].

In this study, we fully characterized the Dutch clinical isolate of APMV-1--like virus, determined its phylogenetic relationship to other APMV-1 strains, and correlated presence of this virus with lesions in tissues obtained from the patient at autopsy. We also examined virulence and excretion pattern of this virus in chickens and domestic pigeons.

METHODS {#s1}
=======

Case Description {#s2}
----------------

A 54-year-old woman with a history of multiple myeloma received an allogenic bone marrow transplant in September 2002, following preparation with a nonmyeloablative regimen (cyclosporin) and while on antifungal therapy (intravenous itraconazole). She initially did well, but was hospitalized 8 weeks after transplantation with symptoms of malaise, anorexia, fever, and abdominal complaints (including abdominal pain, diarrhea, and food intolerance). She lived in the country near to a city, but was not employed in agriculture, and there was no evidence of contact with animals in her clinical history. Gastroscopic examination showed no abnormalities. Infiltrative lesions in the thorax were detected by radiological and computed tomographic examinations, and there was progressive swelling of cervical lymph nodes. No pathogens were detected in bronchoalveolar lavage (BAL) specimens (virus culture on HEL, LLC-MK2, HEp-2, and human rhabdomyosarcoma cells; bacterial culture on blood agar, chocolate agar, Columbia blood agar containing colistin and nalidixic acid, and Sabouraud agar; cytological examination for bacteria, fungi, and *Pneumocystis carinii*), and a biopsy of the peripheral right lower lung lobe was histologically normal. Epstein-Barr virus (EBV) antigen expression and lymphoproliferation were detected in a biopsy of the right jugular lymph node, and a blood sample was positive for EBV DNA by polymerase chain reaction (PCR). Reactivation of EBV and associated lymphoproliferation were treated successfully with rituximab (anti-CD20) and discontinuation of cyclosporin therapy, but other clinical signs remained. Enteroscopic examination of the small intestine showed no abnormalities, and no pathogens were detected in fecal samples by bacterial culture.

Five weeks after hospitalization, the patient developed high fever and progressive worsening of respiratory signs. Treatment with cotrimoxazole was initiated for suspected *P. carinii* infection, and with prednisone for suspected bronchiolitis obliterans organizing pneumonia or graft-vs-host disease of the lung. Two weeks later, the patient developed respiratory failure. There was crepitation over both lung fields and bilateral, progressively expanding, blotchy infiltrates in the thorax by radiological examination. Gram-negative, rod-shaped bacteria (*Pseudomonas* species) were detected by microscopic examination of BAL fluid, and treatment with ceftazidime and tobramycin was initiated. Despite intubation and artificial respiration at increasing pressure, respiratory function deteriorated further and circulatory failure developed. Artificial respiration was stopped after 3 days, after which the patient died.

Autopsy was performed 1 day after death. There were extensive areas of bronchopneumonia associated with *Pseudomonas* species infection in both lungs by bacterial culture. In addition, there was marked diffuse alveolar damage, characterized by abundant hyaline membranes lining the alveolar septa. The mucosa of the colon ascendens was lined by a hemorrhagic exudate, but autolysis was too advanced to confirm or rule out graft-vs-host disease, and no satisfactory explanation was found for the abdominal complaints. In conclusion, the progressive respiratory failure was explained by severe diffuse alveolar damage of undetermined cause, and extensive bilateral bronchopneumonia caused by terminal *Pseudomonas* species infection.

Metagenomic Analysis of Suspect Cell Culture Specimens {#s3}
------------------------------------------------------

As part of an in-depth investigation, archived cell culture samples with an unexplained cytopathic effect were subjected to metagenomic analysis as described previously \[[@CIT0008]\]. These samples included human rhabdomyosarcoma cells inoculated with a BAL specimen collected in 2002 from the above patient. Metagenomic analysis revealed the presence of short nucleotide fragments with homology to APMV-1. To complete the genome of the clinical isolate, fragments obtained through whole transcriptome amplification were assembled against the APMV-1 genome with the highest similarity ([Supplementary Methods](#sup6){ref-type="supplementary-material"}). In brief, the assembly was performed using Sequencher software (version 4.1; Gene Codes). Because the whole-transcriptome amplification fragments did not overlap into a complete genome, the assembly was used to design primers for genome walking, PCR assays were performed with these primers, and products were sequenced. These efforts resulted in the genome completion of the Dutch clinical virus isolate.

Phylogenetic Analysis of the Dutch Clinical Virus Isolate {#s4}
---------------------------------------------------------

Nucleotide sequences were aligned with the Clustal W program running within the BioEdit software package, version 5.0.9 \[[@CIT0012]\]. With the nucleotide sequence alignment, the best-fit model of nucleotide substitution was determined by jModelTest \[[@CIT0013]\]. Maximum-likelihood (ML) phylogenetic trees were generated using the GTR+Γ4+I model of nucleotide substitution and the PhyML package version 3.0 \[[@CIT0014]\]. The reliability of all phylogenetic groupings was determined through a bootstrap resampling analysis of a 1000 replicates with PhyML. Trees were visualized through the FigTree program version 1.4. (<http://tree.bio.ed.ac.uk/software/figtree/>) and rooted on the APMV-1 with the highest BLAST similarity in GenBank (APMV-1/NL/152608/1993).

Virological and Pathological Analyses of Biopsies and Autopsy Specimens {#s5}
-----------------------------------------------------------------------

The following tissue biopsies and autopsy tissue specimens had been fixed in 10% neutral-buffered formalin and embedded in paraffin blocks: heart, lung, jugular lymph node, esophagus, thyroid gland, stomach, pancreas, liver, kidney, skin, diaphragm, and muscle. These specimens were used for detection of APMV-1 RNA by real-time reverse-transcription PCR (RT-PCR), of APMV-1 antigen by immunoperoxidase method, and of histological lesions by hematoxylin and eosin stain ([Supplementary Methods](#sup6){ref-type="supplementary-material"}).

Characterization of Virulence of the Dutch Clinical Virus Isolate for Chickens and Pigeons {#s6}
------------------------------------------------------------------------------------------

Chickens were inoculated intracerebrally with the Dutch clinical virus isolate to determine the intracerebral pathogenicity index ([Supplementary Methods](#sup6){ref-type="supplementary-material"}). Domestic pigeons were inoculated intratracheally with the Dutch clinical virus isolate to determine infectivity and transmissibility, clinical signs, and pathological changes ([Supplementary Methods](#sup6){ref-type="supplementary-material"}).

RESULTS {#s7}
=======

Phylogenetic Analysis {#s8}
---------------------

The sequence of the full-length genome of the Dutch clinical virus isolate displayed 97% nucleotide sequence homology with an APMV-1 isolated from pigeons in Belgium (APMV-1/Belgium/98--238/1998; JX901109). Phylogenetic analysis of full-length genomic sequences of closely related APMV-1 isolates demonstrated that the Dutch clinical isolate clustered among Belgian and Chinese avian strains in genotype VIb/1 ([Figure 1](#F1){ref-type="fig"}). Viruses in this genotype are also called pigeon paramyxovirus type 1 (PPMV-1), because pigeons and doves are the animal reservoir. Therefore, the Dutch clinical virus isolate was named human PPMV-1 (hPPMV-1/NL/579/2003; accession number KJ544861).

![Maximum likelihood phylogenetic tree depicting the relationship of the Dutch clinical isolate (hPPMV-1/NL/579/2003) with related avian paramyxovirus type 1 (APMV-1) strains based on analysis of full-length genomes. Assignment of APMV-1 genotypes (VIb/1 or VII) and sublineages (EUre1, EUre2, EUea1, or EUea2) was based on the studies of Ujvári et al \[[@CIT0016]\] and Czegledi et al \[[@CIT0035]\] and the sequence comparison shown in [Table 1](#T1){ref-type="table"}. GenBank accession numbers are given in parentheses: hPPMV-1/NL/579/2003 (KJ544861), Be/98--238/1998 (JX901109), Be/98--248/1998 (JX901110), WF CHK-guangzhou/2005 (HM063425), IE/806/2004 (JN986839), CH/waterhen/05 (HM063423), CH/SDLC/2011 (JQ979176), CH/LLN/110713 (JX486552), Be/07-04943/2007 (JX901121), Chi/SDS/2011 (JQ993431), Be/11-08304/2011 (JX901123), JS/07/03 (FJ766531), JS/07/22 (FJ766526), JS/07/16 (FJ766527), Be/11-07574/2011 (JX901122), JS/07/04 (FJ766530), CH/LGD/110947 (JX486556), CH/LGD/110945 (JX486555), IE/AV32419/1996 (GQ429292), CH/LJL/100605 (JX486551), CH/LHLJ/110813 (JX486553), CH/LGD/110208 (JX486550), CH/LHLJ/110822 (JX486554), CH/LJL/120404 (JX486557), IT/273620/2000 (GQ429293), USA/0607/2006 (KC013033), IT/227/1982 (AJ880277), USA/0704/2007 (KC013034), USA/0810/2008 (KC013038), USA/0719/2007 (KC013036), USA/0717/2007 (KC013035), USA/0805/2008 (KC013037), USA/NY/1984 (FJ410145), USA/ML/1984 (FJ410147), IT/2736/2000 (AY562989), APMV-1/NL/152608/1993 (JN986837).](jiy03601){#F1}

Comparison of predicted amino acid sequences revealed that all of the hPPMV-1/NL/579/2003 encoded proteins displayed \>95% identity with those of other PPMV-1. In general, the fusion protein (F) cleavage site of medium/high virulent APMV-1s contain the sequence ^113^RQ(K/R)R\*F^117^, while those of low virulent APMV-1s usually have the sequence ^113^(K/R)Q(G/E)R\*L^117^. The cleavage site of hPPMV-1/NL/579/2003 (^113^RQKR\*F^117^) was consistent with a virulent pathotype, similar to that observed in all PPMV-1 (^113^R(Q/K) KR\*F^117^) \[[@CIT0015]\].

Based on phylogenetic analysis of sequences of partial F protein sequences, Ujvári et al identified 4 sublineages of PPMV-1 (ie, APMV-1 genotype VIb/1) strains. These subgroups, designated Iraqi (IQ), early European (EU/ea), North American (NA), and recent European (EU/re), corresponded partly to the times of isolation and/or geographical origin \[[@CIT0016]\]. Alignment of the F protein amino acid sequences from hPPMV-1/NL/579/2003 with those of Ujvári and others revealed that it had identical amino acids substitutions as isolates belonging to sublineage EUR/re2 ([Table 1](#T1){ref-type="table"}). No sequence information was available for this partial F protein sequence of the only other APMV-1 clinical isolate, from a fatal human case in New York state \[[@CIT0011]\]. The available partial sequence for this New York clinical virus isolate demonstrated the closest relationship with a PPMV-1 isolated from pigeons in New York in 2006 (KC013033.1), and clustering in sublineage VIb/1 NA1 (data not shown).

###### 

Amino Acid Sequence (Position on Top) Comparison Around the Proteolytic Cleavage Site of the Fusion Protein Between the Dutch Clinical Isolate (hPPMV-1/NL/579/2003) and Representative Avian Paramyxovirus Type 1 Strains Used for Differentiation of Sublineages

  Strain                 Accession No.^a^   Geno-type   Sub- lineage   8     11    13    14    19    20    22    27    28    49    50    60    63    90    111   112   113   114   115   117
  ---------------------- ------------------ ----------- -------------- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
  Chicken/NL/152608/93   JN986837           VII                        R     V     L     M     I     M     I     C     L     A     V     S     V     T     G     R     R     Q     K     F
  Iraq'78                AY150092           VIb/1       IQ             ...   ...   ...   ...   ...   T     ...   ...   P     ...   ...   ...   ...   ...   ...   ...   ...   ...   ...   ...
  IT-227/1982            AY150093\*         VIb/1       EU/ea1         ...   ...   ...   T     T     ...   ...   ...   P     ...   ...   ...   ...   ...   ...   G     ...   ...   ...   ...
  SE-2/83                AY150100           VIb/1       EU/ea1         ...   ...   ...   T     T     ...   ...   ...   P     ...   ...   ...   ...   ...   ...   G     ...   ...   ...   ...
  DE-209/83              AY150095           VIb/1       EU/ea1         ...   ...   ...   T     T     ...   ...   ...   P     ...   ...   ...   ...   ...   ...   G     ...   ...   ...   ...
  HU-491/87              AY150114           VIb/1       EU/ea2         M     ...   ...   T     T     ...   ...   ...   P     ...   ...   ...   ...   ...   ...   G     ...   ...   ...   ...
  HU-655/89              AY150120           VIb/1       EU/ea2         M     ...   ...   T     T     ...   L     ...   P     ...   ...   ...   ...   ...   ...   G     ...   ...   ...   ...
  USA/NY/1984            FJ410145\*         VIb/1                      M     ...   ...   T     T     ...   ...   ...   P     ...   ...   ...   ...   ...   ...   ...   ...   ...   ...   ...
  USA/ML/1984            FJ410147\*         VIb/1                      M     ...   ...   T     T     ...   ...   ...   P     ...   ...   ...   ...   ...   ...   ...   ...   ...   ...   ...
  US-17/87               AY150116           VIb/1       NA 1           ...   ...   P     ...   ...   ...   ...   ...   Q     ...   I     ...   ...   ...   E     ...   ...   ...   ...   ...
  CA-24/88               AY150117           VIb/1       NA 1           ...   ...   P     ...   ...   ...   ...   ...   Q     ...   I     ...   ...   ...   E     ...   ...   ...   ...   ...
  MX-11/98               AY150152           VIb/1       NA 1           ...   ...   P     ...   ...   V     ...   ...   Q     ...   I     ...   ...   ...   E     ...   ...   ...   ...   ...
  HU-61/83               AY150099           VIb/1       NA 2           ...   ...   P     ...   ...   ...   ...   ...   P     ...   I     ...   ...   ...   E     ...   ...   ...   ...   ...
  DE-47/87               AY150110           VIb/1       NA 2           ...   ...   P     ...   ...   ...   ...   ...   P     ...   I     ...   ...   ...   E     ...   ...   ...   ...   ...
  DK-12/93               AY150138           VIb/1       NA 2           ...   ...   P     ...   ...   ...   ...   ...   P     ...   I     ...   ...   ...   E     ...   ...   ...   ...   ...
  ES-3/92                AY150132           VIb/1       EU/re1         K     A     ...   ...   ...   T     ...   ...   ...   V     I     ...   ...   ...   V     ...   ...   K     ...   ...
  DE-48/92               AY150129           VIb/1       EU/re1         ...   A     ...   ...   ...   T     ...   ...   ...   V     I     ...   ...   ...   V     ...   ...   K     ...   ...
  DE-51/93               AY150133           VIb/1       EU/re1         ...   A     ...   ...   V     T     ...   ...   ...   V     I     ...   ...   ...   V     ...   ...   K     ...   ...
  DE-57/95               AY150143           VIb/1       EU/re1         ...   A     ...   ...   ...   T     ...   ...   ...   V     I     ...   ...   ...   V     ...   ...   K     ...   ...
  DE-2653/98             AY150149           VIb/1       EU/re1         ...   A     ...   ...   ...   T     ...   ...   ...   V     I     ...   ...   ...   ...   ...   ...   K     ...   ...
  IE/AV324/1996          GQ429292\*         VIb/1                      ...   A     ...   ...   ...   T     ...   ...   ...   V     I     ...   ...   ...   V     ...   ...   K     ...   ...
  USA/0607/2006          KC013033\*         VIb/1                      ...   A     ...   ...   ...   T     ...   ...   ...   V     I     ...   ...   ...   V     ...   ...   K     ...   ...
  USA/0704/2007          KC013034\*         VIb/1                      ...   A     ...   ...   ...   T     ...   ...   ...   V     I     ...   ...   ...   V     ...   ...   K     ...   ...
  IT/2736/2000           GQ429293\*         VIb/1                      ...   A     ...   ...   ...   T     T     ...   ...   V     I     ...   ...   ...   V     ...   ...   K     ...   ...
  HU-1G/00               AY150155           VIb/1       EU/re2         ...   A     ...   ...   ...   T     ...   ...   P     ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  YU(Vo)-595/01          AY150164           VIb/1       EU/re2         ...   A     ...   ...   ...   T     ...   ...   P     ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  IT-125/87              AY150115           VIb/1       EU/re2         ...   A     ...   ...   ...   T     ...   ...   P     ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  DE-95/92               AY150130           VIb/1       EU/re2         ...   T     ...   ...   ...   T     ...   ...   P     ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  hPPMV-1/NL/579/2003    KJ544861\*         VIb/1                      ...   A     P     ...   ...   T     V     ...   P     ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  CH/SDLC/2011           JQ979176\*         VIb/1                      ...   A     P     T     ...   T     V     ...   S     ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  Be/11-08304/2011       JX901123\*         VIb/1                      ...   A     ...   T     ...   I     V     ...   S     ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  DE-690/00              AY150154           VIb/1       EU/re2         M     A     ...   ...   ...   T     V     ...   ...   ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  Be/98--248/1998        JX901110\*         VIb/1                      ...   A     ...   ...   ...   T     V     ...   ...   ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  Be/07-04943/2007       JX901121\*         VIb/1                      ...   A     ...   ...   ...   T     V     ...   ...   ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  CH/LGD/110947          JX486556\*         VIb/1                      G     A     P     ...   ...   T     V     R     ...   ...   I     ...   ...   ...   ...   ...   ...   ...   ...   ...
  HR-65/95 e             AY150144           Vib/2                      ...   A     ...   I     ...   T     ...   R     ...   ...   ...   L     I     A     ...   K     ...   ...   ...   ...
  HR-111/01              AY150162           Vib/2                      ...   A     ...   ...   ...   T     ...   R     ...   ...   ...   L     I     A     ...   K     ...   ...   ...   ...
  HR-3/02                AY150165           Vib/2                      ...   A     ...   ...   ...   T     ...   R     ...   ...   ...   L     I     A     ...   K     ...   ...   ...   ...

Source: Ujvári et al \[[@CIT0016]\].

^a^Isolates with an asterisk were used for phylogenetic analysis in [Figure 1](#F1){ref-type="fig"}.

Virological and Pathological Analyses of Biopsies and Autopsy Specimens {#s9}
-----------------------------------------------------------------------

Real-time RT-PCR analysis revealed the presence of high levels of PPMV-1 RNA in the left and right lung ([Table 2](#T2){ref-type="table"}). Lower levels were detected in liver, kidney, and bone marrow, while the remaining tissues tested negative. Immunohistochemistry analysis revealed the expression of PPMV-1 antigen, visible as red-brown granular staining, in the same tissues that tested positive with real-time RT-PCR ([Table 2](#T2){ref-type="table"}). The exact localization of these granules was not clear, although some aggregates of granules appeared to be located in the cytoplasm of degenerate cells ([Figure 2](#F2){ref-type="fig"}). PPMV-1 antigen expression was present in the positive control tissue and absent in the isotype control and negative control tissues.

###### 

Detection of Pigeon Paramyxovirus Type 1 by Real-time Reverse-Transcription Polymerase Chain Reaction and Immunohistochemistry in Tissues Collected From the Patient

  Tissue (No.)          PPMV-1 RNA (Ct)   PPMV-1 Antigen
  --------------------- ----------------- ----------------
  Left lung (n = 2)     31                \+
  21                    ++                
  Right lung (n = 3)    25                ++
  23                    \+                
  27                    ++                
  Liver (n = 1)         31                \+
  Left kidney (n = 1)   33                \+
  Bone marrow (n = 1)   37                \+

Heart, esophagus, stomach, pancreas, right kidney, skin, diaphragm, and muscle tested negative for PPMV-1 RNA by real-time reverse-transcription polymerase chain reaction and for PPMV-1 antigen by immunohistochemistry; lung biopsy and lymph node biopsy tested negative for PPMV-1 antigen by immunohistochemistry.

Abbreviations: +, rare positive granules; ++, occasional positive granules; Ct, cycle threshold; PPMV-1, pigeon paramyxovirus type 1.

![Pulmonary immunohistochemistry and histopathology of the patient with hPPMV-1/NL/579/2003 infection. *A*, Diffuse alveolar damage, characterized by thickening of alveolar septa, flooding of alveolar lumina, and presence of hyaline membranes (hematoxylin and eosin \[H&E\] staining; original magnification ×4.) *B*, Higher magnification of *A*, showing single pulmonary alveole, where epithelial lining is replaced by hyaline membranes (H&E; original magnification ×40.) *C*, Avian paramyxovirus type 1 antigen visible as granular staining in cytoplasm of degenerate cell, suggestive of alveolar epithelial cell (immunoperoxidase stain for pigeon paramyxovirus type 1 \[PPMV-1\]; original magnification ×100.).](jiy03602){#F2}

Histopathological examination demonstrated that PPMV-1 antigen--expressing sections of lung had diffuse alveolar damage, characterized by loss of alveolar epithelium, rare hypertrophic type II pneumocytes, widened alveolar septa, and fibrin thrombi in alveolar capillaries ([Figure 2](#F2){ref-type="fig"}). No histological lesions were apparent in other tissues that expressed PPMV-1 antigen, or in PPMV-1-negative tissues.

Characterization of hPPMV-1/NL/579/2003 in Chickens and Pigeons {#s10}
---------------------------------------------------------------

Based on intracerebral inoculation into 1-day-old chickens, the intracerebral pathogenicity index of hPPMV-1/NL/579/2003 was 0.164 ([Supplementary Table 2](#sup2){ref-type="supplementary-material"}). This corresponds with a lentogenic pathotype. In pigeons, all 5 intratracheally inoculated animals developed a productive infection, with shedding from the pharynx between 2 and 10 dpi, and from the cloaca between 7 and 17 dpi ([Supplementary Figure 1](#sup3){ref-type="supplementary-material"}). Virus was transmitted to 1 of the 2 naive pigeons. None of the pigeons displayed clinical signs at any time point during the 3-week observation period. No gross lesions were observed in any pigeons at autopsy at 21 dpi. However, histopathological analysis showed that all 5 intratracheally inoculated pigeons plus the 1 infected naive pigeon had diffuse interstitial nonpurulent nephritis, which was absent in 2 negative control pigeons from the same flock ([Supplementary Figure 2](#sup4){ref-type="supplementary-material"}). Also, 1 inoculated pigeon had multifocal nonpurulent pancreatitis. Real-time RT-PCR analysis revealed that hPPMV-1/NL/579/2003 was present in the kidney sample of 3 inoculated pigeons with nephritis, and in the pancreas sample of 2 inoculated pigeons, including the 1 with pancreatitis ([Supplementary Figure 3](#sup5){ref-type="supplementary-material"}).

DISCUSSION {#s11}
==========

We diagnosed PPMV-1 infection as the cause of diffuse alveolar damage in the Dutch female patient, based on colocalization of PPMV-1 antigen, high loads of PPMV-1 RNA, and characteristic histological lesions in autopsy specimens ([Figure 2](#F2){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). The PPMV-1--associated diffuse alveolar damage was exacerbated by bronchopneumonia due to *Pseudomonas* species infection, probably from intravenous catheterization. The combination of these 2 pulmonary diseases likely explains the severe respiratory failure leading to the death of this immunosuppressed patient.

It is rare to diagnose PPMV-1 infection as the cause of severe respiratory disease in humans. To our knowledge, the only other known case was reported by the New York State Department of Health in 2007 \[[@CIT0011]\]. It is not clear whether this paucity of reports is because the disease is rare or because APMV-1, including PPMV-1, is not suspected in such cases. We suggest that APMV-1, including PPMV-1, should be included in the differential diagnosis of cases of respiratory disease that test negative for more common respiratory pathogens. Samples could be tested by various molecular methods, such as a family-wide RT-PCR assay for paramyxoviruses or metagenomics approaches \[[@CIT0018], [@CIT0019]\].

When they became infected with PPMV-1, the Dutch and New York patients were receiving immunosuppressive therapy to improve the success of peripheral blood stem cell or bone marrow transplantation. There is an increase in the proportion of immunocompromised people in the population \[[@CIT0020]\]. As these immunocompromised people are at high risk of severe disease from other opportunistic infections \[[@CIT0020]\], they also may be at risk of severe disease from infection with APMV-1, including PPMV-1.

PPMV-1 appears to target the lower respiratory tract epithelium in humans. This is based on the demonstration of PPMV-1 antigen expression in the alveolar epithelium of autopsy lung samples from both human cases ([Figure 2](#F2){ref-type="fig"}) \[[@CIT0011]\]. The tissue tropism of PPMV-1 in these 2 human cases resembles that of other emerging zoonotic respiratory viruses---H5N1 influenza virus and the severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses---that also target the lower respiratory tract \[[@CIT0020], [@CIT0022]\].

There was evidence of extrarespiratory spread of PPMV-1 in the Dutch case. This was based on evidence of PPMV-1 infection in liver, kidney, and bone marrow ([Table 2](#T2){ref-type="table"}). This is consistent with the New York case, where evidence of PPMV-1 infection in feces and urine also suggested extrarespiratory spread \[[@CIT0011]\]. The immunosuppressive state of the Dutch and New York patients may have allowed spread of PPMV-1 beyond the respiratory tract.

Pigeons and doves are the animal reservoir of PPMV-1 ([Figure 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). In Europe, these viruses are circulating predominantly in domestic pigeons (*Columba livia domestica*) or their wild relatives (rock pigeons, *C. livia*), and other members of the family Columbidae, especially Eurasian collared doves (*Streptopelia decaocto*) and European turtle doves (*Streptopelia turtur*) \[[@CIT0015]\]. The tropism of hPPMV-1/NL/579/2003 for the kidney and pancreas of experimentally infected pigeons ([Supplementary Figures 2 and 3](#sup4 sup5){ref-type="supplementary-material"}) matches the tissue tropism of PPMV-1 in naturally infected pigeons \[[@CIT0025]\]. The low pathogenicity of this isolate in chickens fits with the phenotype of other PPMV-1 strains \[[@CIT0026]\].

The number of feral pigeons---free-living birds that have descended from domestic pigeons---in European and North American cities increased substantially from the 1940s to the 1970s as a result of changes in agricultural practices and the rapid human population increase after World War II. Feral pigeon numbers then stabilized, likely due to reaching the carrying capacity of the urban environment. However, population growth of feral pigeons is still likely to occur in recently colonized cities and at the newly built outskirts of cities \[[@CIT0027]\].

First reported in Italy in 1981 \[[@CIT0028]\], PPMV-1 subsequently spread across Europe and has become endemic in feral pigeons, with regular spread to wild pigeons and doves \[[@CIT0015]\]. In North America, PPMV-1 was introduced in the 1980s and now is maintained endemically in pigeons and doves \[[@CIT0029]\], including the Eurasian collared dove \[[@CIT0029], [@CIT0030]\]. This invasive species, first reported in Florida in the 1980s, has rapidly spread across most of North America (<http://www.audubon.org/field-guide/bird/eurasian-collared-dove>), and could facilitate virus dispersal throughout North America \[[@CIT0029], [@CIT0030]\].

The clinical histories of the Dutch and New York cases do not readily explain how they became infected. The Dutch patient lived in a rural area near a city, but was not employed in agriculture, and there was no evidence of contact with animals (this study). The New York patient was an urban dweller, but it is unknown whether he had pets or was exposed to birds in other settings \[[@CIT0011]\]. Based on phylogenetic analysis of the viruses, the most probable route of transmission was contact with infected pigeons or doves. PPMV-1 is environmentally stable in bird feces and can be spread by direct contact or by windborne dust \[[@CIT0031]\].

The route of transmission of other zoonotic pathogens from pigeons to humans may be instructive. Five pathogen species (*Chlamydia psittaci*, *Histoplasma capsulatum*, *Aspergillus* species, *Candida parapsilosis*, and *Cryptococcus neoformans*) have been reported to be routinely transmitted from feral pigeons to people \[[@CIT0032]\], mostly by inhalation of airborne excreta, including dried feces, ocular discharges, and crop milk. Contact was sometimes brief, and patients did not always recall any encounters with birds. It is relevant for these PPMV-1 cases that the risk of 2 pigeon-associated diseases---chlamydiosis and cryptococcosis---was largely a function of the immune status of patients, rather than contact with infected birds \[[@CIT0032], [@CIT0033]\].

Close contact between feral pigeons and humans commonly occurs in squares, public gardens, parks, markets, and railway stations in urban areas \[[@CIT0033]\]. Therefore, people in urban areas are likely to have a higher rate of contact with feral pigeons than in rural areas. The proportion of the global human population living in urban areas is increasing. In 1950, 30% of the world's population lived in urban areas; this increased to 54% in 2014, and by 2050, 66% of the world's population is projected to be urban \[[@CIT0034]\]. This suggests that the number of people at risk of contracting zoonotic infections, including PPMV-1, from feral pigeons will increase in coming decades. The combination of the above factors---large populations of feral pigeons with endemic PPMV-1 infection, increasing urbanization, and a higher proportion of immunocompromised individuals---may increase the risk of severe human cases of PPMV-1 infection.
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